Register now
View webcast
Interim Report for Fisher & Paykel Healthcare for the 2022 financial year.
31 March 2022 2022 Financial Year End
25 May 2022 Full Year Results Announcement 26 May 2022 Investor Day July 2022† Full Year Dividend
24 August 2022* Annual Shareholders' Meeting
30 September 2022 Financial Half Year End November 2022 Half Year Results Announcement December 2022† Interim Dividend
FPH
Daily volume
Annual average dailyvolume
52 week range
Compare with:
A short overview of Fisher & Paykel Healthcare's history, financial performance, business areas and management team.
Shareholders should address questions relating to dividends, certificates or changes of address to Fisher & Paykel Healthcare's share registrar, Link Market Services Limited.
LINK Market Services Limited Level 11, Deloitte House 80 Queen Street Auckland 1010 P O Box 91976 Auckland 1142 Investor enquiries: +64 9 375 5998 Fax: +64 9 375 5990 enquiries@linkmarketservices.co.nz
LINK Market Services Limited Level 12, 680 George Street Sydney, NSW 2000 Locked Bag A14 Sydney South NSW 1235 Investor enquiries: +61 2 8280 7111 Fax: +61 2 9287 0303 registrars@linkmarketservices.com.au
For all other investor inquiries contact
hayden.brown@fphcare.co.nz
Phone: +64 9 574 0116 extn 7323
Fisher & Paykel Healthcare is listed on the NZX Main Board and Australian Securities Exchange and is governed by the rules of those exchanges. Fisher & Paykel Healthcare does not sponsor, sanction, support or encourage trading in Fisher & Paykel Healthcare shares through third and fourth markets, such as ADR programmes and over the counter trading. Fisher & Paykel Healthcare disclaims any liability whatsoever arising out of any trading through third and fourth markets, including unsponsored ADR programmes and over the counter trading.
Sign up to receive email notifications of the latest investor news from Fisher & Paykel Healthcare.
Evidence and guidance for delivering Optiflow NHF, proven respiratory support for your patients.
Featuring under nose NIV masks and full face NIV masks, with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Delivering warm, humidified carbon dioxide in laparoscopic and open surgery
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment